In–depth insights to navigate our changing world
We explore the questions to ask and signals to look for to help better understand our changing world.
Learn more about the trends shaping this ‘business unusual’ environment and how they may impact the future of capital markets.
Data and tech disruption are providing navigational insights for companies and investors as the speed and scale of dealmaking across sectors hits new highs
Alice Crawley, Managing Director at UBS discusses how due diligence and deal discovery is changing with the Wall Street Journal Custom Content team.
COVID-19 has thrust us into an era of huge uncertainty, for investors and corporate decision–makers, this new environment poses a multitude of complex questions.
Barry Hurewitz, Group Managing Director, Global Head of Evidence Lab Innovations UBS, discusses his team’s mission is to surface relevant insights with the Wall Street Journal Custom Content team.
UBS Research argues the COVID-19 pandemic could act as a catalyst to increased life expectancy over the long-term, thanks to improvements in health tech, a policy pivot on obesity and a positive shift in consumer attitudes towards health.
COVID-19 won’t mark a turning point for globalization itself, reveals new research from UBS, as it’s been in retreat for the better part of 15 years. However post-pandemic, globalization may move from slowdown to complete stasis, if supply chains shorten, protectionism including in services increases and Chinese growth moves towards more homegrown consumption.
Insights, implications and sign-posts to track on the impact of COVID-19 from across our investment banking research teams globally.
As regions reopen and activity returns, see what the latest insights from UBS Evidence Lab reveal.
Data-driven insights to help you answer the questions that matter to your decisions
